The__O research__O outcomes__O above__O and__O the__O related__O body__O of__O research__O (see__O reference__O 3.1)__O have__O been__O embodied__O in__O the__O Molpro__B-LOC software__O (http://www.molpro.net),__O which__O has__O been__O developed,__O supported__O and__O distributed__O under__O licence__O since__O 2004.__O
Since__O 2008,__O there__O have__O been__O three__O major__O releases__O of__O the__O software__O (2008,__O 2010__O and__O 2012)__O at__O which__O new__O capabilities__O have__O been__O added__O as__O a__O result__O of__O research__O in__O theory__O and__O methods.__O
Impact__O on__O Practitioners__B-ORG and__I-ORG Professional__I-ORG Services__I-ORG The__O value__O of__O Molpro__B-ORG is__O that__O it__O offers__O key__O functionality__O (in__O particular__O local__O correlation__O for__O large__O molecules;__O multireference__O methods__O for__O chemical__O reactions__O and__O excited__O states)__O that__O are__O not__O available__O in__O Gaussian__B-LOC (the__O industry-standard__O general__O purpose__O code)__O or__O any__O other__O code__O [5.1].__O
A__O wide__O range__O of__O companies,__O each__O operating__O on__O an__O international__O basis,__O has__O opted__O to__O use__O Molpro,__B-PER as__O a__O new__O process__O that__O offers__O enhanced__O capabilities,__O to__O enable__O the__O development__O and__O production__O of__O a__O plethora__O of__O products__O that__O are__O marketed__O to__O industries__O including__O agriculture,__O aerospace,__O construction,__O automotive,__O pharmaceutical,__O packaging__O and__O personal__O care.__O
The__O list__O includes__O BASF,__B-ORG Sasol,__I-ORG Schr&#246;dinger,__I-ORG Bristol-Myers-Squibb,__I-ORG Mitsubishi__I-ORG Chemical__I-ORG Group__I-ORG and__O Nissan__B-ORG Chemical__I-ORG Industries.__I-ORG
BASF,__O for__O example__O (an__O organisation__O that__O has__O over__O 380__O production__O sites__O worldwide__O and__O produces__O a__O range__O of__O products__O for__O eight__O industries),__O purchased__O Molpro__B-ORG in__O 2011.__O
Ansgar__B-ORG Sch&#228;fer,__I-ORG the__I-ORG Group__I-ORG Leader__I-ORG in__O Quantum__B-LOC Chemistry__I-LOC at__O BASF,__B-LOC states__O that__O "Molpro,__B-ORG and__O in__O particular__O its__O capability__O for__O very__O accurate__O computations__O on__O large__O molecules,__O has__O become__O a__O valuable__O tool__O for__O estimating__O thermochemical__O and__O kinetic__O data__O for__O substances__O and__O reactions__O involved__O in__O our__O development__O of__O new__O materials__O and__O processes"__O [5.2].__O
Similarly,__B-MISC Bristol-Myers-Squibb__I-MISC (BMS),__I-MISC which__O has__O 26__O facilities__O in__O 10__O countries__O and__O manufactures__O prescription__O drugs__O to__O treat__O diseases__O such__O as__O cancer,__O HIV/AIDS,__B-ORG cardiovascular__O disease,__O diabetes,__O hepatitis__O and__O rheumatoid__O arthritis,__O acquired__O Molpro__B-ORG in__O 2008.__O
Dan__B-ORG Cheney,__I-ORG Group__I-ORG Leader__I-ORG at__I-ORG BMS,__I-ORG commented__O that__O "In__O the__O Bristol-Myers__B-ORG Squibb__I-ORG CADD__I-ORG group,__O we__O believe__O that__O effective__O drug__O design__O rests__O on__O an__O affordable__O and__O acceptable__O level__O of__O scientific__O rigor.__O
Among__O quantum__O chemistry__O programs,__O Molpro__B-PER is__O unique__O in__O enabling__O us__O to__O do__O this__O by__O offering__O coupled__O cluster__O code__O that__O can__O be__O applied__O to__O drug-like__O systems__O using__O reasonable__O computational__O resources"__O [5.3].__O
No__O other__O package__O is__O competitive__O on__O this__O basis.__O
Molpro__O has__O significantly__O progressed__O industrial__O knowledge__O and__O capabilities.__O
Economic__O Gain__B-PER Molpro__I-PER has__O resulted__O in__O significant__O economic__O gain,__O manifested__O in__O a)__O the__O number__O of__O licences__O sold,__O and__O b)__O the__O augmentation__O of__O corporations__O authorised__O to__O resell__O the__O software.__O
a)__B-ORG Licences__I-ORG sold__O Between__O 1/1/2008__O and__O 31/7/2013,__O 780__O paid-for__O Molpro__B-PER licences__O were__O issued.__O
Total__O sales,__O including__O those__O effected__O by__O sales__O agents__O and__O net__O of__O their__O commission,__O amounted__O to__O &#163;1,783,714.__O
As__O a__O result__O of__O this,__O several__O posts__O have__O been__O created__O in__O Cardiff__B-LOC to__O support__O the__O work,__O to__O achieve__O further__O sales__O and__O to__O develop__O activities__O in__O Stuttgart,__B-ORG Lund,__I-ORG Regensburg,__I-ORG Bristol__I-ORG and__O Uppsala.__B-LOC
Sales__O are__O continuing__O to__O increase,__O as__O demonstrated__O by__O the__O six__O monthly__O income__O figures;__O in__O October__O 2012,__O the__O amount__O was__O &#163;179,535,__O but__O by__O April__O 2013__O this__O had__O risen__O to__O &#163;290,132__O [5.4].__O
b)__O Companies__O reselling__O the__O software__O There__O are__O presently__O twelve__O authorised__O resellers__O of__O the__O software__O that__O have__O reaped__O considerable__O financial__O gain__O from__O the__O sale__O of__O Molpro.__B-LOC
Examples__O are__O Beijing__B-LOC Hongcam__I-ORG Software__I-ORG Technologies__I-ORG Co.__I-ORG and__O Ryoka__B-ORG Systems,__I-ORG Inc.__I-ORG Ryoka__I-ORG Systems__I-ORG have__O stated__O that,__O during__O the__O REF__O period,__O sales__O of__O Molpro__B-ORG amounted__O to__O &#163;145,143__O [5.5].__O
Molpro__O sales__O have__O continued__O to__O increase;__O there__O was__O a__O 19%__O increase__O for__O the__O period__O 2008-2010__O compared__O to__O 2005-2007,__O while__O in__O the__O last__O two__O and__O a__O half__O years__O the__O software__O has__O remained__O a__O source__O of__O ongoing__O profit__O for__O Ryoka.__B-LOC
Similarly,__B-ORG Beijing__I-ORG Hongcam__I-ORG Software__I-ORG Technologies__I-ORG has__O accumulated__O sizeable__O financial__O benefit__O from__O distributing__O Molpro;__B-ORG during__O the__O REF__B-ORG period,__O sales__O amounted__O to__O &#163;82,705__O [5.4].__O
